These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21802286)

  • 1. Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease.
    Tiew KC; He G; Aravapalli S; Mandadapu SR; Gunnam MR; Alliston KR; Lushington GH; Kim Y; Chang KO; Groutas WC
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5315-9. PubMed ID: 21802286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.
    Namoto K; Sirockin F; Sellner H; Wiesmann C; Villard F; Moreau RJ; Valeur E; Paulding SC; Schleeger S; Schipp K; Loup J; Andrews L; Swale R; Robinson M; Farady CJ
    Bioorg Med Chem Lett; 2018 Mar; 28(5):906-909. PubMed ID: 29433930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
    Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
    Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
    Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST
    J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K.
    Marquis RW; Yamashita DS; Ru Y; LoCastro SM; Oh HJ; Erhard KF; DesJarlais RL; Head MS; Smith WW; Zhao B; Janson CA; Abdel-Meguid SS; Tomaszek TA; Levy MA; Veber DF
    J Med Chem; 1998 Sep; 41(19):3563-7. PubMed ID: 9733481
    [No Abstract]   [Full Text] [Related]  

  • 6. Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements.
    Webber SE; Okano K; Little TL; Reich SH; Xin Y; Fuhrman SA; Matthews DA; Love RA; Hendrickson TF; Patick AK; Meador JW; Ferre RA; Brown EL; Ford CE; Binford SL; Worland ST
    J Med Chem; 1998 Jul; 41(15):2786-805. PubMed ID: 9667969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putative structural rearrangements associated with the interaction of macrocyclic inhibitors with norovirus 3CL protease.
    Galasiti Kankanamalage AC; Weerawarna PM; Rathnayake AD; Kim Y; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    Proteins; 2019 Jul; 87(7):579-587. PubMed ID: 30883881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution.
    Zeitler CE; Estes MK; Venkataram Prasad BV
    J Virol; 2006 May; 80(10):5050-8. PubMed ID: 16641296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Amino-α'-halomethylketones: synthetic methodologies and pharmaceutical applications as serine and cysteine protease inhibitors.
    Pace V; Castoldi L; Pregnolato M
    Mini Rev Med Chem; 2013 Jun; 13(7):988-96. PubMed ID: 22931530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease.
    Kawatkar SP; Gagnon M; Hoesch V; Tiong-Yip C; Johnson K; Ek M; Nilsson E; Lister T; Olsson L; Patel J; Yu Q
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3248-3252. PubMed ID: 27265257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of chloromethyl sulfoxides as a new class of selective irreversible cysteine protease inhibitors.
    Brouwer AJ; Bunschoten A; Liskamp RM
    Bioorg Med Chem; 2007 Nov; 15(22):6985-93. PubMed ID: 17869119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71.
    Zhang L; Huang G; Cai Q; Zhao C; Tang L; Ren H; Li P; Li N; Huang J; Chen X; Guan Y; You H; Chen S; Li J; Lin T
    J Mol Recognit; 2016 Nov; 29(11):520-527. PubMed ID: 27185390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives.
    Lavrado J; Mackey Z; Hansell E; McKerrow JH; Paulo A; Moreira R
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6256-60. PubMed ID: 22926067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Evaluation of Novel Prodrugs of Transition State Inhibitors of Norovirus 3CL Protease.
    Galasiti Kankanamalage AC; Kim Y; Rathnayake AD; Alliston KR; Butler MM; Cardinale SC; Bowlin TL; Groutas WC; Chang KO
    J Med Chem; 2017 Jul; 60(14):6239-6248. PubMed ID: 28671827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
    Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
    J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
    Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
    Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype.
    Myers MC; Shah PP; Beavers MP; Napper AD; Diamond SL; Smith AB; Huryn DM
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3646-51. PubMed ID: 18499453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 6-substituted amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one derivatives as cysteine proteases inhibitors.
    Zhou NE; Guo D; Kaleta J; Purisima E; Menard R; Micetich RG; Singh R
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3413-5. PubMed ID: 12419373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain.
    Huang L; Ellman JA
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2993-6. PubMed ID: 12270191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of keto-glutamine analogues as inhibitors of hepatitis A virus 3C proteinase.
    Ramtohul YK; James MN; Vederas JC
    J Org Chem; 2002 May; 67(10):3169-78. PubMed ID: 12003522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.